This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Molecular Tumor Board Series

Molecular Tumor Board Series

Format

Patient Case Study

Time to Complete

1 hour

Released

June 4, 2019

Expires

December 5, 2019
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider



This activity is provided by the Academy for Continued Healthcare Learning (ACHL).

Commercial Supporters

This activity is supported by an educational grant from Roche®.

Program Description

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: breast cancer, large cell neuroendocrine carcinoma of the lung, sinonasal undifferentiated carcinoma of the head & neck, and adenocarcinoma of the lung.

Intended Audience

Physicians or other clinicians who particpate in molecular tumor boards.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Utilize skills learned to implement an effective tumor board.
  • Describe genomic testing.
  • Implement genomic profiling into oncology treatment.

Conflict Of Interest Disclosure Policy

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.

Faculty

Shayma Master Kazmi, MD, RPh
Medical Oncologist and Hematologist
Cancer Treatment Centers of America

Dr. Kazmi has no relevant financial relationships to disclose.

Arturo Loaiza-Bonilla, MD, MSEd, FACP
Vice Chair Department of Medical Oncology
Cancer Treatment Centers of America

Dr. Loaiza-Bonilla disclosed that he received consulting fees from Guardant Health, Astra Zeneca, and Bayer; is on the speaker’s bureau for Celgene; and has ownership interest in Massive Bio.

Bradford Tan, MD
Chair Department of Pathology and Laboratory Medicine
Cancer Treatment Centers of America

Dr. Tan has no relevant financial relationships to disclose.

Scott Price, MD
Vice Chair Department of Radiology
Cancer Treatment Centers of America

Dr. Price has no relevant financial relationships to disclose.

Pamela Crilley, DO
Chair Department of Medical Oncology
Cancer Treatment Centers of America

Dr. Crilley has no relevant financial relationships to disclose.

Ankur Parikh, DO
Medical Director Precision Medicine
Cancer Treatment Centers of America

Dr. Parikh disclosed that he received consulting fees from Foundation Medicine.

David Topolsky, MD
Medical Oncologist
Cancer Treatment Centers of America

Dr. Toplosky has no relevant financial relationships to disclose.

Alan Tan, MD
Medical Director Cancer Research – Phoenix
Cancer Treatment Centers of America

Dr. Tan disclosed that he is on the speaker’s bureau for Bristol Myers Squibb and Astrazeneca.

Maurie Markman, MD
President Medicine & Science
Cancer Treatment Centers of America

Dr. Markman disclosed that he received consulting fees from Celgene, Myriad, and Massive Bio; and is on the speaker’s bureau for Clovis, Tesaro and Genentech.

Vicki Doctor, BSN, RN
Senior Specialist Precision Medicine
Cancer Treatment Centers of America

Ms. Doctor has no relevant financial relationships to disclose.

Ricardo Alvarez, MD, MSc
Director Breast Cancer Institute
Cancer Treatment Centers of America

Dr. Alvarez disclosed that he received consulting fees from Esai, Novartis and Pfizer.

Julian Schink, MD
Chief Division of Gynecological Oncology
Cancer Treatment Centers of America

Dr. Schink has no relevant financial relationships to disclose.

Planners Disclosures

The planners for this activity have no relevant financial relationships to disclose. The planning committee includes: Kate Petersen, Susan Zook, Jaci Brown, MEd, Amanda Woodward, RN, Vicki Doctor, BSN, RN, and Sarah Lees, MS, MEd, MHA.

Accredited Provider Disclosures

The members of the ACHL team have no relevant financial relationships to disclosure.

Publishing Staff Disclosures

Sarah Lees, MS, MEd, MHA, Kate Peterson, and Jaci Brown, MEd, have no relevant financial relationships to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and Cancer Treatment Centers of America. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Academy for Continued Healthcare Learning designates that this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM .  Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Disclaimer

Participants have implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

Instructions

In order to receive credit, participants must complete the pre-assessment questions, post-test, and program evaluation. Participants must also score at least 100% on the posttest. There is no limit on the number of times they may take the test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

For information about the accreditation of this program, please contact Melissa Stradal at mstradal@achlcme.org.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue